These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32946322)

  • 1. 2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging.
    Salib MY; Russell JHB; Stewart VR; Sudderuddin SA; Barwick TD; Rockall AG; Bharwani N
    Radiographics; 2020 Oct; 40(6):1807-1822. PubMed ID: 32946322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.
    Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ
    Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
    Haldorsen IS; Lura N; Blaakær J; Fischerova D; Werner HMJ
    Curr Oncol Rep; 2019 Jul; 21(9):77. PubMed ID: 31359169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality Imaging of Uterine Cervical Malignancies.
    Mansoori B; Khatri G; Rivera-Colón G; Albuquerque K; Lea J; Pinho DF
    AJR Am J Roentgenol; 2020 Aug; 215(2):292-304. PubMed ID: 32551909
    [No Abstract]   [Full Text] [Related]  

  • 5. Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging.
    Saleh M; Virarkar M; Javadi S; Elsherif SB; de Castro Faria S; Bhosale P
    AJR Am J Roentgenol; 2020 May; 214(5):1182-1195. PubMed ID: 32182097
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of the new FIGO staging and the role of imaging in cervical cancer.
    Kido A; Nakamoto Y
    Br J Radiol; 2021 Sep; 94(1125):20201342. PubMed ID: 33989030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain.
    Salvo G; Odetto D; Pareja R; Frumovitz M; Ramirez PT
    Int J Gynecol Cancer; 2020 Jun; 30(6):873-878. PubMed ID: 32241876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
    Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
    Morkel M; Ellmann A; Warwick J; Simonds H
    Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients.
    Hancke K; Heilmann V; Straka P; Kreienberg R; Kurzeder C
    Ann Surg Oncol; 2008 Oct; 15(10):2856-61. PubMed ID: 18696156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI and PET scans for primary staging and detection of cervical cancer recurrence.
    Liyanage SH; Roberts CA; Rockall AG
    Womens Health (Lond); 2010 Mar; 6(2):251-67; quiz 268-9. PubMed ID: 20187730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values of ADC
    Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
    J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging.
    Lee SI; Atri M
    Radiology; 2019 Jul; 292(1):15-24. PubMed ID: 31135294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.
    Meva J; Chaudhary RK; Bhaduri D; Bhatia M; Hatti S; Ba R
    Int J Gynecol Cancer; 2013 Jul; 23(6):1071-7. PubMed ID: 23792602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Parametrial Status in Locally Advanced Cervical Cancer Patients after Neoadjuvant Chemotherapy: A Prospective Study on Diagnostic Accuracy of Three-Dimensional Transvaginal Ultrasound.
    Perniola G; Fischetti M; Tomao F; Di Donato V; Palaia I; Santangelo G; Lecce F; Piccioni MG; Muzii L; Benedetti Panici P
    Oncology; 2020; 98(9):603-611. PubMed ID: 32492692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls.
    Balcacer P; Shergill A; Litkouhi B
    Abdom Radiol (NY); 2019 Jul; 44(7):2557-2571. PubMed ID: 30903231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.
    Pandharipande PV; Choy G; del Carmen MG; Gazelle GS; Russell AH; Lee SI
    AJR Am J Roentgenol; 2009 Mar; 192(3):802-14. PubMed ID: 19234280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
    Simonds H; Botha MH; Ellmann A; Warwick J; Doruyter A; Neugut AI; Van Der Merwe H; Jacobson JS
    Int J Gynecol Cancer; 2019 Oct; 29(8):1252-1257. PubMed ID: 31413068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
    Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
    Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.